Vasogen-- VAS on TSE Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Vasogen-- VAS on TSE

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: caly who wrote (290)	7/24/2005 7:22:35 PM
From: Pluvia	Read Replies (2) of 377

Vasogen is an interesting company, but they have some issues with their technology. Vasogen has what i would describe as "limited" positive results, with significant questions as to the mechanism that's driving their results. 1. They also have serious problems increasing their dosing because they can't identify specifically what's in their "drug"; 2. Without the ability to identify exactly what's in their drug, they may hit a wall during drug approval; or be severely restricted to the limited dose they're currently using. 3. this is an issue because others using similar "drugs" CAN identify specifically what's in their drug and therefore, can easily increase their dose. IMO that means others will leapfrog Vasogen and perform studies with MUCH better results... leaving Vasogen in the dust. When the FDA is presented with two drugs similar in nature with similar or identical patient responses, and one identifies EXACTLY what's in their drug... and the other does not... IMO the FDA requires Vasogen to identify EXACTLY what's in their drug... Vasogen's equipment cannot do this.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next